DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Health IT Homepage

Why is (almost) no one billing for remote patient monitoring? Using mobile to monitor patients at home can boost care quality — and revenue streams

Simplifying population health management and the identification of social determinants with natural language processing

Vulnerabilities found in infusion pump firmware Could enable dose or infusion rate manipulation

How important is protecting the patient health information (PHI) to your vendors? Outsourcing services comes with risks that must be addressed

Informatics, standardization and the next phase for enterprise imaging Life after silos is coming into focus

Enterprise content management (ECM) systems are the rise Offering better data security, market may exceed $1.3 billion by 2023

Financial details of nearly 12 million patients at risk following AMCA breach Includes social security numbers, credit cards and medical information

Agfa investigates sale of Hospital IT and Integrated Care business Shedding $213 million unit will position company mainly as imaging vendor

Verasonics settles legal dispute over software with SuperSonic Imagine Alleged patent infringement and misappropriate of trade secrets

Healthcare devices vulnerable due to legacy Windows operating systems: survey As Microsoft phases out old products, the install base remains

NAVIFY Tumor Board 2.0

Roche and GE Healthcare release NAVIFY Tumor Board 2.0

John R. Fischer , Staff Reporter
Roche and GE Healthcare have released NAVIFY Tumor Board 2.0, the first in a number of products slated to be unveiled by the two that will facilitate greater personalized treatment decisions in cancer care.

Equipped with medical image viewing and storage capabilities for other forms of patient data, the solution accumulates medical records from multiple sources in one place, which acts as a reference from which tumor boards can evaluate and gain better understanding of individual patients.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



"Managing tumor boards can be labor intensive and time consuming for healthcare providers because it often requires manually collecting and organizing patient information from various sources — radiology and microscope slide images from PACS systems, pathology reports, electronic medical records and a lot more," Ketan Paranjape, vice president of diagnostics information solutions at Roche Diagnostics, told HCB News. "As a result, clinicians often don’t have time to gain a holistic view of a patient’s relevant medical history, potentially having to delay diagnosis or make a treatment decision that doesn’t take into account all of the available data."

The system is part of the NAVIFY Decision Support portfolio, a group of products that help clinicians derive actionable insights from large amounts of data for clinical decision-making across the entire care continuum. Among them is the most recent prior version of the solution, NAVIFY Tumor Board, a cloud-based software solution that streamlines and standardizes preparation, and facilitates and documents treatment decisions by the oncology team.

NAVIFY Tumor Board 2.0 comprises GE Healthcare’s medical imaging viewer, which enables radiologists to upload patient records to the same dashboard where patient files from other disciplines of the cancer care team are stored. This enables specialists to use the limited time they have during tumor boards to review relevant files quickly and determine together the best possible approach for treating each patient.

It also leverages Roche’s expertise in advanced lab testing, furthering the confidence of users in their decision-making. Plans are in place for future developments.

"The software is designed to create a centralized repository of tumor board data, and it currently offers apps that enable oncology care teams to match the patient to available clinical trials, reference clinical guidelines and search for relevant published studies," said Paranjape. "In the near future, it will also allow cross-referencing to patient pools, to see how similar patients were managed in the past, and remote participation of experts from outside the location during the meeting, facilitating the concept of virtual tumor boards."

The system is available in the U.S. and Canada, with additional market launches set to follow.

Health IT Homepage


You Must Be Logged In To Post A Comment

Advertise
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
Jobs/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
Recently Certified
查看最近通过认证的用户
Recently Rated
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
Service Technicians Forum
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2019 DOTmed.com, Inc.
版权所有